Bruce Thompson, PhD.

Strategic Advisor

Bruce is currently the CEO of Kincell Bio, LLC., a newly formed cell therapy CDMO focused on supporting the CMC needs of early phase startup biotech companies and academic spinouts. Prior to his role with Kincell Bio, LLC., he was Vice President and Technical Lead for the Cell Therapy Franchise at Resilience, Inc., where he helped to build the development and GMP manufacturing capabilities and served as a technical advisor both internally and externally. He has over 18 years of CMC strategy, product development and cell therapy manufacturing experience.